Effectiveness of Manual Therapy in Non-specific Low Back Pain

August 11, 2022 updated by: JORGE VELAZQUEZ SAORNIL, Universidad Católica de Ávila

Effectiveness of Dry Needling VS Ischaemic Compression on Latent Myofascial Myofascial Trigger Points in the Gluteus Medius in Patients With Patients With Non-specific Low Back Pain: a Randomised Clinical Trial

Low back pain affects many people and involves high medical costs. For this reason, we wish to test the efficacy of dry needling VS ischaemic compression in patients with non-specific low back pain. To this end, an investigation was carried out on 40 patients diagnosed with this ailment, divided into two groups by randomisation to assess the intensity of pain, range of movement, pain threshold to pressure and quality of life, measuring these variables prior to the intervention, immediately, at 48 hours and one week after the intervention.

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ávila, Spain, 05005
        • Universidad Católica de Ávila

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Signed informed consent form.
  • Presence of non-specific low back pain for more than six weeks.
  • Presence of a palpable tight band nodule in the gluteus medius muscle.
  • Presence of a hypersensitive or hyperirritable point in the tight band.
  • Patients reporting local or referred pain in the area of the latent MGP after mechanical stimulation mechanical stimulation.

Exclusion Criteria:

  • Surgeries in the lumbopelvic region.
  • Diagnosis of herniated discs in the lumbar region.
  • Positive cognitive screening according to the Pfeiffer questionnaire.
  • Heterometrics.
  • Age outside the range of 18 to 75 years.
  • Ingested or injected anticoagulant or antiplatelet drugs.
  • Systemic or local infection in the lumbar region.
  • Pregnancy.
  • Presence of fear of needles (belonephobia).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: dry needling group
Dry needling of the trigger point of the gluteus medius in patients diagnosed with non-specific low back pain.
Active Comparator: ischaemic compression group
Ischaemic trigger point compression of the gluteus medius in patients diagnosed with non-specific low back pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain
Time Frame: 1 week
Visual Scale Analogue (0 minimum, 10 maximum).
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
movement
Time Frame: 1 week
Schober test (0 minimum, 45 maximun).
1 week
quality of life
Time Frame: 1 week

Oswestry low back pain disability scale (0 minimum, 100% maximum; Between 0-20% minimal limitation or disability, 21-40% moderate limitation or disability, 41- 60% severe limitation or disability, 61-80% disabled and above 81% limitation or disability.

60% severe limitation or disability, 61-80% disabled and above 81% maximum functional limitation or disability, 61-80% disabled and above 81% maximum functional limitation or disability.

maximum functional limitation).

1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2022

Primary Completion (Actual)

May 29, 2022

Study Completion (Actual)

June 24, 2022

Study Registration Dates

First Submitted

June 23, 2022

First Submitted That Met QC Criteria

June 28, 2022

First Posted (Actual)

June 30, 2022

Study Record Updates

Last Update Posted (Actual)

August 15, 2022

Last Update Submitted That Met QC Criteria

August 11, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 230622

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on dry needling

3
Subscribe